Moreover, unlike many epithelial markers, such as EpCAM and CK19 that usually disappear during circulation and metastasis as a result of epithelial to mesenchymal transition (EMT)53–55, these conserved CSC markers hold a great potential as the reliable biomarkers for monitoring cancer progression and predicting prognosis. The gene discussed is EPCAM; the disease is cancer.